Epix President Andrew Uprichard: An Interview With "The Pink Sheet" DAILY
A day after Epix announces plans to further appeal two FDA "approvable" letters for Vasovist, Uprichard discusses why he's taking his case to CDER Director Steve Galson.
A day after Epix announces plans to further appeal two FDA "approvable" letters for Vasovist, Uprichard discusses why he's taking his case to CDER Director Steve Galson.